The new era of diagnostics: will it ever start?

H. Goossens (Edegem (Antwerp), Belgium)

Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Goossens (Edegem (Antwerp), Belgium). The new era of diagnostics: will it ever start?. International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The new horizons of molecular diagnosis: do we still need conventional microbiology?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Facing a new era: how does the pandemic change sleep medicine and practice?
Source: Sleep and Breathing Conference 2021
Year: 2021


Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016

Advances in targeted therapy: the clinicians point of view
Source: International Congress 2014 – Update on lung cancer biology for clinicians
Year: 2014



NORDSTAR: paving the way for a new era in asthma research
Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019
Year: 2020



How to stop LC-fILD progression: an overview of modern therapeutic strategies
Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists
Year: 2021


Global tuberculosis prevention: should we start from the beginning?
Source: Eur Respir J, 54 (3) 1901394; 10.1183/13993003.01394-2019
Year: 2019



The new perspectives in chest imaging: back to the future?
Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Year: 2020


Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future?
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Year: 2019


MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



A new era for Assembly 1: general pneumology
Source: Breathe, 15 (2) 147; 10.1183/20734735.0135-2019
Year: 2019



From traditional bacteriology to rapid molecular methods: the revolution is going on
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012



From Bench to edside: Development of a drug to treat lung disease from a basic research start
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009


Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018
Year: 2018



From the bedside: upcoming new clinical strategies
Source: International Congress 2016 – Scientific Year in Review 2016
Year: 2016


Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
Source: Eur Respir J 2004; 23: 793-794
Year: 2004


Target volume setting: great progress or gadget?
Source: International Congress 2014 – Technical refinements in home mechanical ventilation: what is useful, what is irritating, and what is gadgetry?
Year: 2014



What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018